1. Home
  2. INUV vs XLO Comparison

INUV vs XLO Comparison

Compare INUV & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$2.97

Market Cap

47.2M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.54

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
XLO
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.2M
39.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
INUV
XLO
Price
$2.97
$0.54
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$12.67
$2.00
AVG Volume (30 Days)
279.4K
443.8K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
50.00
60.79
EPS
N/A
N/A
Revenue
N/A
$6,344,000.00
Revenue This Year
$11.72
$626.78
Revenue Next Year
$3.89
$79.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.50
52 Week High
$6.27
$1.18

Technical Indicators

Market Signals
Indicator
INUV
XLO
Relative Strength Index (RSI) 62.85 41.38
Support Level $2.39 $0.50
Resistance Level $3.10 $0.74
Average True Range (ATR) 0.30 0.04
MACD 0.17 0.00
Stochastic Oscillator 70.22 28.94

Price Performance

Historical Comparison
INUV
XLO

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: